We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current LNSR market cap is 47.4M. The company's latest EPS is USD -1.2622 and P/E is -3.30.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 10.23M | 8.25M | 12.01M | 9.8M | 12.11M |
Operating Income | -2.61M | -4.36M | -2.87M | -2.04M | -2.96M |
Net Income | -2.49M | -4.27M | -8.75M | 2.57M | -3.93M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 30.53M | 26.38M | 34.46M | 35.36M | 42.16M |
Operating Income | -12.71M | -18.5M | -19.65M | -20.18M | -12.23M |
Net Income | -14.66M | -19.77M | -19.6M | -19.91M | -14.38M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 55.84M | 51.96M | 71.2M | 70.85M | 69.59M |
Total Liabilities | 13.86M | 12.52M | 24.76M | 20.72M | 22.41M |
Total Equity | 41.98M | 39.44M | 32.69M | 36.38M | 33.43M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 34.54M | 79.12M | 66.47M | 55.84M | 69.59M |
Total Liabilities | 65.09M | 11.91M | 11.59M | 13.86M | 22.41M |
Total Equity | -30.55M | 67.21M | 54.88M | 41.98M | 33.43M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -14.86M | -6.7M | -8.84M | -9.18M | -9.66M |
Investing | -115k | -8k | -189k | -191k | -4.16M |
Financing | -1.99M | N/A | 19.82M | 19.62M | 19.76M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -12.59M | -13.79M | -8.97M | -14.86M | -9.66M |
Investing | -2.09M | -326k | -354k | -115k | -4.16M |
Financing | 15.95M | 50M | 361k | -1.99M | 19.76M |
Market Cap | 47.4M |
Price to Earnings Ratio | -3.30 |
Price to Sales Ratio | 1.12 |
Price to Cash Ratio | 2.3 |
Price to Book Ratio | 1 |
Dividend Yield | - |
Shares Outstanding | 11.4M |
Average Volume (1 week) | 32.55k |
Average Volume (1 Month) | 37.71k |
52 Week Change | 86.55% |
52 Week High | 5.30 |
52 Week Low | 1.80 |
Spread (Intraday) | 1.21 (26.95%) |
Company Name | LENSAR Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.lensar.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions